Gavin O'Dowd
CEO
Replay available
Haypp Group AB (publ) (STO: HAYPP) Q1 2026 earnings conference call, held 2026-05-07. Replay captured from the company's public earnings webcast.

CEO
CFO
Analyst, Pareto Securities
Analyst, Barclays
Analyst, Deutsche Bank
Watch the replay and follow the connected company analysis, news, and investor updates for Haypp Group Ab.
WEBVTT 00:00:00.031 -- 00:00:03.074 Welcome to Hype Group Q1 2026. 00:00:03.074 -- 00:00:07.619 For the first part of the conference call, the participants will be in listen-only mode. 00:00:07.619 -- 00:00:12.584 During the questions and answers session, participants are able to ask questions by dialing 00:00:12.584 -- 00:00:17.249 pound key five on their telephone keypad. Now I will hand the conference over to the 00:00:17.249 -- 00:00:20.873 speakers, CEO Gavin O'Dowd and CFO Peter Deli. 00:00:20.873 -- 00:00:23.353 Please go ahead. 00:00:24.276 -- 00:00:29.225 Good morning, everyone, and welcome to Hype Group's Q1 results. 00:00:29.225 -- 00:00:35.112 Our CFO, Peter Deli, and I, Gavin O'Dowd, will take you through today's presentation. 00:00:35.276 -- 00:00:40.144 Starting at slide three, which is the agenda for today, I will take you through an overview 00:00:40.144 -- 00:00:45.894 of hype and the Q1 performance highlights, and Peter will take us through the consumer, 00:00:45.894 -- 00:00:51.263 financial, and segment performances before having a look at the progress on our key strategic 00:00:51.263 -- 00:00:55.046 priority markets and an outlook. 00:00:55.516 -- 00:00:59.682 I would like to take you to slide five to remind you of some of the key dynamics around 00:00:59.682 -- 00:01:01.244 our business. 00:01:01.244 -- 00:01:06.211 We are a retailer of risk-reduced products with a strong focus on nicotine patches, which 00:01:06.211 -- 00:01:11.236 as of today make up approximately 70% of our sales. 00:01:11.619 -- 00:01:16.786 We have multiple storefronts per market, and we operate in six markets in Europe 00:01:16.786 -- 00:01:21.993 and in the US. Approximately 90% of our revenue comes from product sales, 00:01:21.993 -- 00:01:27.578 with the sales of medi...